001     878237
005     20210615092724.0
024 7 _ |2 Handle
|a 2128/25471
037 _ _ |a FZJ-2020-02706
041 _ _ |a German
088 _ _ |2 JUEL
|a Juel-4425
100 1 _ |0 P:(DE-Juel1)132740
|a Humpert, Swen
|b 0
|e Corresponding author
|g male
|u fzj
245 _ _ |a Entwicklung von Kupplungsmethoden mit neuen Markierungsbausteinen zur Synthese $^{18}$F-markierter PSMA-selektiver Liganden und argininreicher all-D Peptide
|f - 2020-04-30
260 _ _ |a Jülich
|b Forschungszentrum Jülich GmbH Zentralbibliothek, Verlag
|c 2020
300 _ _ |a VII, 160 S.
336 7 _ |2 DataCite
|a Output Types/Dissertation
336 7 _ |0 PUB:(DE-HGF)3
|2 PUB:(DE-HGF)
|a Book
|m book
336 7 _ |2 ORCID
|a DISSERTATION
336 7 _ |2 BibTeX
|a PHDTHESIS
336 7 _ |0 2
|2 EndNote
|a Thesis
336 7 _ |0 PUB:(DE-HGF)11
|2 PUB:(DE-HGF)
|a Dissertation / PhD Thesis
|b phd
|m phd
|s 1597147156_383
336 7 _ |2 DRIVER
|a doctoralThesis
490 0 _ |a Berichte des Forschungszentrums Jülich
|v 4425
502 _ _ |a Universität Köln, Diss., 2020
|b Dissertation
|c Universität Köln
|d 2020
520 _ _ |a Positron emission tomography (PET) is an indispensable tool in clinical research and diagnostics for the visualization of physiological and pathophysiological processes at themolecular level $\textit{in vivo}$. For different clinical examinations, PET requires radiolabeled, tailormade molecules, so called radiotracers, specifically targeting selected molecular structures. The development and efficient production of these tracers is therefore an essential task in PETresearch. Direct radiolabeling approaches with $^{18}$F, one of the most suitable radionuclides for PET, require harsh reaction conditions and are often not applicable for sensitive biomolecules. However, indirect methods using radiolabeled building blocks are well suited as alternatives although they are more time consuming due to multi step syntheses and thus less effective. The aim of this work was the further development and application of novel indirect radiolabeling methods for peptides. Accordingly, two different peptides have been used for radiolabeling. Radiolabeled PSMA-selective ligands and arginine-rich, fully D-enantiomeric peptides (D3 and RD2) should be prepared in this work. PSMA-selective peptidomimetics are currently being used for the detection of prostate carcinoma and the D-enantiomeric peptides in Alzheimer's research since they potentially enable a causal treatment of this disease which is otherwise not possible so far. For the conjugation of the promising synthon (Z)-2-[$^{18}$F]fluorohex-1-en-1-yl(phenyl)iodoniumtosylate ([$^{18}$F]FHexI$^{+}$), various Pd-catalyzed cross-coupling reactions were first investigated using structurally simple coupling partners. After radiosynthesis of [$^{18}$F]FHexI$^{+}$ under aqueous conditions starting from [$^{18}$F]fluoride, subsequently both, the Sonogashira coupling and the Suzuki coupling reaction were carried out as a one-pot reaction directly in the initial labelling mixture. [...]
536 _ _ |0 G:(DE-HGF)POF3-573
|a 573 - Neuroimaging (POF3-573)
|c POF3-573
|f POF III
|x 0
856 4 _ |u https://juser.fz-juelich.de/record/878237/files/J%C3%BCl_4425.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:878237
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)132740
|a Forschungszentrum Jülich
|b 0
|k FZJ
913 1 _ |0 G:(DE-HGF)POF3-573
|1 G:(DE-HGF)POF3-570
|2 G:(DE-HGF)POF3-500
|3 G:(DE-HGF)POF3
|4 G:(DE-HGF)POF
|a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|v Neuroimaging
|x 0
914 1 _ |y 2020
915 _ _ |0 StatID:(DE-HGF)0510
|2 StatID
|a OpenAccess
915 _ _ |0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
|a Creative Commons Attribution CC BY 4.0
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-5-20090406
|k INM-5
|l Nuklearchemie
|x 0
980 _ _ |a phd
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a book
980 _ _ |a I:(DE-Juel1)INM-5-20090406
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21